Thiosemicarbazide-Substituted Coumarins as Selective Inhibitors of the Tumor Associated Human Carbonic Anhydrases IX and XII

Molecules. 2022 Jul 19;27(14):4610. doi: 10.3390/molecules27144610.

Abstract

A novel series of thiosemicarbazide-substituted coumarins was synthesized and the inhibitory effects against four physiologically relevant carbonic anhydrase isoforms I, II, IX and XII showed selective activities on the tumor-associated IX and XII isozymes. Molecular modeling studies on selected compounds 14a and 22a were performed. The binding modes of such compounds were determined assuming their enzymatically active structures (i.e., cinnamic acid) in the thermodynamically favored, and not previously explored, E geometry. Molecular modelling suggests multiple interactions within the enzymatic cavity and may explain the high potency and selectivity reported for the hCAs IX and XII.

Keywords: carbonic anhydrase inhibitors; coumarins; privileged scaffolds; thiosemicarbazides.

MeSH terms

  • Antigens, Neoplasm / metabolism
  • Carbonic Anhydrase I
  • Carbonic Anhydrase IX / chemistry
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology
  • Carbonic Anhydrases* / chemistry
  • Coumarins / chemistry
  • Coumarins / pharmacology
  • Humans
  • Molecular Structure
  • Neoplasms* / drug therapy
  • Semicarbazides
  • Structure-Activity Relationship

Substances

  • Antigens, Neoplasm
  • Carbonic Anhydrase Inhibitors
  • Coumarins
  • Semicarbazides
  • thiosemicarbazide
  • Carbonic Anhydrase I
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases

Grants and funding

This research received no external funding.